Terms: = Head and neck cancer AND ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR-1, MXR1, UAQTL1 AND Treatment
83 results:
1. Exposure to Secondhand Smoke Extract Increases Cisplatin Resistance in head and neck cancer Cells.
Sadhasivam B; Manyanga J; Ganapathy V; Acharya P; Bouharati C; Chinnaiyan M; Mehta T; Mathews B; Castles S; Rubenstein DA; Tackett AP; Zhao YD; Ramachandran I; Queimado L
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256106
[TBL] [Abstract] [Full Text] [Related]
2. USP10 suppresses abcg2-induced malignant characteristics of doxorubicin-resistant thyroid cancer by inhibiting PI3K/AKT pathway.
Sun J; Xiang Q; Ding D; Yan N
J Bioenerg Biomembr; 2023 Dec; 55(6):457-466. PubMed ID: 37919637
[TBL] [Abstract] [Full Text] [Related]
3. Pilot Study on the Impact of Polymorphisms Linked to Multi-Kinase Inhibitor Metabolism on Lenvatinib Side Effects in Patients with Advanced Thyroid cancer.
Cantara S; Dalmiglio C; Marzocchi C; Sagnella A; Brilli L; Trimarchi A; Maino F; Valerio L; Castagna MG
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982571
[TBL] [Abstract] [Full Text] [Related]
4. Impact of transforming growth factor beta 1 on normal and thyroid cancer side population cells.
Latar NM; Mahkamova K; Elson J; Karnik I; Sutherland R; Aspinall S; Meeson A
Endocrine; 2022 May; 76(2):359-368. PubMed ID: 35118633
[TBL] [Abstract] [Full Text] [Related]
5. Stress hormone norepinephrine incites resistance of oral cancer cells to chemotherapy.
Tjioe KC; Cardoso DM; Oliveira SHP; Bernabé DG
Endocr Relat Cancer; 2022 Mar; 29(4):201-212. PubMed ID: 35099408
[TBL] [Abstract] [Full Text] [Related]
6. HOTTIP is upregulated in esophageal cancer and triggers the drug resistance.
Li Y; Liu Y; Chen G; Liu H; Wu Y; Liu J; Zhang Z
J BUON; 2021; 26(3):1056-1061. PubMed ID: 34268972
[TBL] [Abstract] [Full Text] [Related]
7. Polymorphism of
Yang Y; Jia J; Sun Z; Liu C; Li Z; Xiao Y; Yu J; Du F; Shi Y; Sun J; Shui J; Zhang X
Future Oncol; 2021 Jun; 17(18):2351-2363. PubMed ID: 33709789
[TBL] [Abstract] [Full Text] [Related]
8. Differential expression of ABCB1, abcg2, and KLF4 as putative indicators for paclitaxel resistance in human epithelial type 2 cells.
Duz MB; Karatas OF
Mol Biol Rep; 2021 Feb; 48(2):1393-1400. PubMed ID: 33506275
[TBL] [Abstract] [Full Text] [Related]
9. Natural Compounds Modulate Drug Transporter Mediated Oral cancer treatment.
Yang H; Wei YC; Li WC; Chen HY; Lin HY; Chiang CP; Chen HM
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32957726
[TBL] [Abstract] [Full Text] [Related]
10. Hedgehog signaling promotes multidrug resistance by regulation of ABC transporters in oral squamous cell carcinoma.
Lu X; Wang Z; Huang H; Wang H
J Oral Pathol Med; 2020 Oct; 49(9):897-906. PubMed ID: 32512620
[TBL] [Abstract] [Full Text] [Related]
11. Pharmacological effects of vinorelbine in combination with lenvatinib in anaplastic thyroid cancer.
Di Desidero T; Orlandi P; Gentile D; Banchi M; Alì G; Kusmic C; Armanetti P; Cayme GJ; Menichetti L; Fontanini G; Francia G; Bocci G
Pharmacol Res; 2020 Aug; 158():104920. PubMed ID: 32461187
[TBL] [Abstract] [Full Text] [Related]
12. Cigarette Smoke Reduces the Efficacy of Cisplatin in head and neck cancer Cells - Role of abcg2.
Simon F; Schwenk-Zieger S; Becker S; Unger K; Gires O; Baumeister P
Anticancer Res; 2020 Mar; 40(3):1277-1284. PubMed ID: 32132024
[TBL] [Abstract] [Full Text] [Related]
13. GPER mediates decreased chemosensitivity via regulation of abcg2 expression and localization in tamoxifen-resistant breast cancer cells.
Yu T; Cheng H; Ding Z; Wang Z; Zhou L; Zhao P; Tan S; Xu X; Huang X; Liu M; Peng M; Qiu YA
Mol Cell Endocrinol; 2020 Apr; 506():110762. PubMed ID: 32087276
[TBL] [Abstract] [Full Text] [Related]
14. Cisplatin-induced programmed cell death ligand-2 expression is associated with metastasis ability in oral squamous cell carcinoma.
Sudo S; Kajiya H; Okano S; Sasaki M; Katsumata Y; Ohno J; Ikebe T; Hiraki A; Okabe K
Cancer Sci; 2020 Apr; 111(4):1113-1123. PubMed ID: 32012401
[TBL] [Abstract] [Full Text] [Related]
15. Atezolizumab in combination with bevacizumab, paclitaxel and carboplatin for the first-line treatment of patients with metastatic non-squamous non-small cell lung cancer, including patients with
Reck M; Shankar G; Lee A; Coleman S; McCleland M; Papadimitrakopoulou VA; Socinski MA; Sandler A
Expert Rev Respir Med; 2020 Feb; 14(2):125-136. PubMed ID: 31829747
[No Abstract] [Full Text] [Related]
16. Tepotinib reverses ABCB1-mediated multidrug resistance in cancer cells.
Wu ZX; Teng QX; Cai CY; Wang JQ; Lei ZN; Yang Y; Fan YF; Zhang JY; Li J; Chen ZS
Biochem Pharmacol; 2019 Aug; 166():120-127. PubMed ID: 31078601
[TBL] [Abstract] [Full Text] [Related]
17. Influence of CYP3A4/5 and ABC transporter polymorphisms on lenvatinib plasma trough concentrations in Japanese patients with thyroid cancer.
Ozeki T; Nagahama M; Fujita K; Suzuki A; Sugino K; Ito K; Miura M
Sci Rep; 2019 Apr; 9(1):5404. PubMed ID: 30931962
[TBL] [Abstract] [Full Text] [Related]
18. Over-expression of miR-206 decreases the Euthyrox-resistance by targeting MAP4K3 in papillary thyroid carcinoma.
Liu F; Yin R; Chen X; Chen W; Qian Y; Zhao Y; Jiang Y; Ma D; Hu T; Yu T; Zhu Y; Zhang Y
Biomed Pharmacother; 2019 Jun; 114():108605. PubMed ID: 30904818
[TBL] [Abstract] [Full Text] [Related]
19. Predictors of cisplatin-induced ototoxicity and survival in chemoradiation treated head and neck cancer patients.
Teft WA; Winquist E; Nichols AC; Kuruvilla S; Richter S; Parker C; Francis P; Trinnear M; Lukovic J; Bukhari N; Choi YH; Welch S; Palma DA; Yoo J; Kim RB
Oral Oncol; 2019 Feb; 89():72-78. PubMed ID: 30732962
[TBL] [Abstract] [Full Text] [Related]
20. Effects of long noncoding RNA (linc-VLDLR) existing in extracellular vesicles on the occurrence and multidrug resistance of esophageal cancer cells.
Chen Y; Liu L; Li J; Du Y; Wang J; Liu J
Pathol Res Pract; 2019 Mar; 215(3):470-477. PubMed ID: 30606658
[TBL] [Abstract] [Full Text] [Related]
[Next]
